Alpine Woods Capital Investors LLC lowered its position in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 31.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 38,968 shares of the technology company's stock after selling 17,898 shares during the quarter. Alpine Woods Capital Investors LLC's holdings in Amdocs were worth $3,566,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. Farther Finance Advisors LLC grew its position in Amdocs by 17.5% during the first quarter. Farther Finance Advisors LLC now owns 988 shares of the technology company's stock valued at $90,000 after purchasing an additional 147 shares in the last quarter. Cambridge Investment Research Advisors Inc. grew its position in Amdocs by 7.8% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 6,738 shares of the technology company's stock valued at $616,000 after purchasing an additional 490 shares in the last quarter. SBI Securities Co. Ltd. purchased a new position in Amdocs during the fourth quarter valued at approximately $41,000. HighTower Advisors LLC grew its position in Amdocs by 20.0% during the fourth quarter. HighTower Advisors LLC now owns 15,374 shares of the technology company's stock valued at $1,309,000 after purchasing an additional 2,561 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its position in Amdocs by 55.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock worth $50,000 after acquiring an additional 208 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company's stock.
Amdocs Stock Performance
NASDAQ:DOX traded down $0.58 during trading hours on Friday, hitting $88.66. 594,341 shares of the company traded hands, compared to its average volume of 661,524. Amdocs Limited has a twelve month low of $78.58 and a twelve month high of $95.41. The stock has a market capitalization of $10.01 billion, a price-to-earnings ratio of 18.64, a P/E/G ratio of 1.51 and a beta of 0.52. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.21. The firm has a 50-day moving average of $91.64 and a 200 day moving average of $88.29.
Amdocs (NASDAQ:DOX - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.07. Amdocs had a net margin of 11.39% and a return on equity of 19.52%. The company had revenue of $1.13 billion during the quarter, compared to analysts' expectations of $1.12 billion. During the same quarter in the prior year, the company posted $1.56 EPS. The business's revenue was down 9.4% on a year-over-year basis. On average, analysts forecast that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Monday, June 30th will be issued a $0.527 dividend. This represents a $2.11 annualized dividend and a dividend yield of 2.38%. The ex-dividend date is Monday, June 30th. Amdocs's payout ratio is 44.21%.
Wall Street Analyst Weigh In
Several research firms have commented on DOX. Wolfe Research began coverage on shares of Amdocs in a research report on Tuesday. They issued an "outperform" rating for the company. Wall Street Zen raised shares of Amdocs from a "hold" rating to a "buy" rating in a research report on Saturday, June 7th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $105.33.
Check Out Our Latest Analysis on Amdocs
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Stories

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.